EBP22

Entera Bio Ltd. · Phase 1 active Small molecule

At a glance

Generic name	EBP22
Also known as	hPTH(1-34)
Sponsor	Entera Bio Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

EBP22 CI brief — competitive landscape report
EBP22 updates RSS · CI watch RSS
Entera Bio Ltd. portfolio CI